← ClaudeAtlas

pathology-tumor-board-summarylisted

Generates concise 3-5 line tumor board summaries from full pathology reports, extracting the diagnosis, TNM stage, margins, lymph node status, key biomarkers, and risk factors that drive MDT decisions. Use when the user pastes or uploads a pathology report (.pdf, .docx, .txt) and asks to "create a tumor board summary", "MDT summary", "oncology consult summary", "3-line summary for the MDT", or "summarize for tumor board".
sbalci/pathology-skills-collection · ★ 0 · Data & Documents · score 61
Install: claude install-skill sbalci/pathology-skills-collection
# Tumor Board Summary Generator Convert detailed pathology reports into concise 3-5 line summaries for multidisciplinary tumor boards. ## When to Use This Skill Use this skill for: - Multidisciplinary tumor board (MDT) meetings - Oncology consultations - Clinical case presentations - Referral summaries - Quick pathology review ## Supported Tumor Types All cancer types (breast, colorectal, pancreas, gastric, and general carcinomas) ## Key Features 1. **Concise Format**: 3-5 lines maximum 2. **Key Elements**: Patient, diagnosis, stage, margins, nodes, biomarkers 3. **Clinical Focus**: Only clinically actionable information 4. **Ready for Presentation**: No formatting needed ## Reference Files Reference on-demand (DO NOT load at startup): - Summary guidelines: `../../shared-references/common/tumor_board_summary.md` ## Usage Examples ```bash # Generate summary claude "Create tumor board summary using tumor-board-summary" < report.txt # Quick MDT summary claude "Summarize for tumor board using tumor-board-summary" < breast_report.txt ``` ## Processing Instructions 1. **Extract key elements** from pathology report: - Patient demographics (age, sex) - Diagnosis (tumor type, grade) - TNM stage - Margins status - Lymph node status - Key biomarkers (ER/PR/HER2/MSI/HER2) 2. **Format concisely**: 3-5 lines, bullet or paragraph format 3. **Output**: Clinical summary ready for MDT presentation ## Summary Format Template **Line 1**: Patient demographics +